Compare 10X Genomics Inc (TXG) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs State Street SPDR S&P Biotech ETF — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: 10X Genomics Inc is trading nearer its 52-week high, State Street SPDR S&P Biotech ETF nearer its low. Which is the better fit depends on your goals.
| TXG | XBI | |
|---|---|---|
Market Cap | $5.48B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $45.80 | $164.28 |
52-Week Low | $11.34 | $85.16 |
Enterprise Value | $5.02B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
